In this study, we used the C57BL/6J mouse strain to generate Kindlin-2-deficient mice in mammary epithelial cells with the ultimate goal of assessing the consequences of mammary gland-specific knockout of Kindlin-2 on breast cancer development and metastasis. The gene discussed is FERMT2; the disease is breast carcinoma.